DxS announced this week the appointment of Jeff Devlin as chief operating officer. Prior to DxS, Devlin was executive VP and executive committee member of Shire Pharmaceuticals, and a partner in Ernst and Young's life science division.
The company noted that Devlin's appointment is one of a number of new promotions and hires planned for 2009. DxS has doubled its workforce size in the last year after opening a new manufacturing space in Manchester, UK, and signing a global distribution deal with Roche Molecular Diagnostics for its TheraScreen diagnostic kits.